Vexev
Vexev is a Sydney medtech company founded in 2018 by UNSW PhDs Dr John Carroll and Dr Eamonn Colley. It makes VxWave, a robotic, AI-guided ultrasound system that lets non-specialist staff scan blood vessels in the arm, starting with dialysis patients.
In August 2026 it raised a round to fund FDA 510(k) clearance and a US launch. Investors include Blackbird, Neotribe, Startmate and TEN13.
- Sector
- Vascular imaging medtech
- Business model
- Med-tech (robotic imaging hardware + AI)
- Founded
- 2018
- Founders
- John Carroll, Eamonn Colley
- Headquarters
- Sydney
- Markets
- Australia, US
- Total raised
- US$10-50M
Sources: dealroom.co, mobihealthnews.com, seedtable.com
1person interviewed
1episode across 1 show
3backers heard on Day One
The team on Day One
Hear from the team
Milestones
- 2018 Co-founded by John Carroll and Eamonn Colley from UNSW research seedtable.com
- Nov 2022 Raised $8.5M led by Neotribe Ventures startupdaily.net
- 2025 Raised US$6M for FDA clearance and US commercialisation mobihealthnews.com
In the news
Backers heard on Day One
Blackbird Ventures Seed · 4 on Day One 
TEN13 Series A · 1 on Day One 
Startmate Series A · 1 on Day One Also backed by Neotribe Ventures, Horizon, Alumni Ventures, Bioshore Ventures.
Sources: dealroom.co
Spot something wrong? Suggest a correction Updated 25 September 2026